Unusual neurophysiological and immunological findings in myasthenia gravis: A case report

Journal of the Peripheral Nervous System

Volumn 9, Issue 2, 2004, Pages 92-97

  Scaioli, Vidmer ^a   Andreetta, Francesca ^b   Mantegazza, Renato ^b  

^a Ist Naz Neurologico Carlo Besta ^*  (Italy)

^b Immunol and Muscular Pathology Unit   (Italy)

Author keywords

Chronic inflammatory demyelinating polyradiculoneuropathy; Diabetes; Myokymia; Ocular myasthenia gravis; Peripheral nerve hyperexcitability

Indexed keywords

AZATHIOPRINE; CHOLINERGIC RECEPTOR ANTIBODY; GANGLIOSIDE GQ 1B; PREDNISONE; PYRIDOSTIGMINE; VOLTAGE GATED POTASSIUM CHANNEL;

AGED; ARTICLE; CASE REPORT; CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY; CLINICAL FEATURE; DEMYELINATION; DIABETES MELLITUS; DIABETIC NEUROPATHY; DISEASE ASSOCIATION; DISEASE COURSE; DOSE RESPONSE; EXCITABILITY; GASTROINTESTINAL SYMPTOM; HUMAN; IMMUNOPATHOGENESIS; IMMUNOPATHOLOGY; MALE; MUSCLE ACTION POTENTIAL; MUSCLE WEAKNESS; MYASTHENIA GRAVIS; NERVE STIMULATION; NEUROPATHOLOGY; NEUROPHYSIOLOGY; PRIORITY JOURNAL; SEROLOGY; TREATMENT OUTCOME;

AGED; DIABETES MELLITUS, TYPE 2; DIABETIC NEUROPATHIES; ELECTROPHYSIOLOGY; GANGLIOSIDES; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MALE; MYASTHENIA GRAVIS;

EID: 2442660146     PISSN: 10859489     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1085-9489.2004.09207.x     Document Type: Article

References (16)

1. Dyck PJ, Giannini C (1996). Pathological alterations in the diabetic neuropathies of humans: a review. J Neuropathol Exp Neurol 55:1181-1193.
2. Hart IK, Maddison P, Newson-Davis J, Vincent A, Mills KR (2002). Phenotypic variants of autoimmune peripheral nerve hyperexcitability. Brain 125:1887-1895.
3. Heidenreich F, Vincent A (1998). Antibodies to ion-channel proteins in thymoma with myasthenia, neuromyotonia and peripheral neuropathy. Neurology 50:1483-1485.
4. Martinelli P, Patuelli A, Minardi C, Cau A, Riviera AM, Dal Pozzo F (1996). Neuromyotonia, peripheral neuropathy and myasthenia gravis. Muscle Nerve 19:505-510.
5. Musser WS, Barbano RL, Thornton CA, Moxley RT, Hermann DN, Logigian EL (2001). Distal myasthenia gravis with a decrement, an increment, and denervation. J Clin Neuromuscul Dis 3:16-19.
6. Mygland A, Vincent A, Newsom-Davis J, Kaminski H, Zorzato F, Agius M, Gilhus NE, Aarli JA (2000). Autoantibodies in thymoma-associated myasthenia gravis with myositis or neuromyotonia. Arch Neurol 57:527-531.
7. Nations SP, Wolfe GI, Amato AA, Jackson CE, Bryan WW, Barohn RJ (1999). Distal myasthenia gravis. Neurology 52: 632-634.
8. Newsom-Davis J, Mills KR (1993). Immunological associations of acquired neuromyotonia (Isaacs' syndrome). Report of five cases and literature review. Brain 116:453-469.
9. Nicolas G, Maisonobe T, LeForestier N, Leger JM, Bouche P (2002). Proposed revised electrophysiological criteria for chronic inflammatory demyelinating polyradiculoneuropathy. Muscle Nerve 25:26-30.
10. O'Hanlon GM, Plomp JJ, Chakrabarti M, Morrison I, Wagner ER, Goodyear CS, Yin X, Trapp BD, Conner J, Molenaar PC, Stewart S, Rowan EG, Willison HJ (2001). Anti-GQ1b ganglioside antibodies mediate complement-dependent destruction of the motor nerve terminal. Brain 124:893-906.
11. Patwa HS, Fecko JF, Goldstein JM (1996). Concurrent myasthenia gravis and chronic inflammatory demyelinating polyneuropathy. Muscle Nerve 19:1059-1060.
12. Sharma KR, Farronay O, Cross J, Santiago F, Ayyar DR, Bradley WG (2001). Prevalence of chronic inflammatory demyelinating polyneuropathy-like syndromes in diabetes mellitus. Neurology 56:A293.
13. Thomas PK (1997). Classification, differential diagnosis, and staging of diabetic peripheral neuropathy. Diabetes 46: S54-S57.
14. Uncini A, Lugaresi A (1999). Fisher syndrome with tetraparesis and antibody to GQ1b: evidence for motor nerve terminal block. Muscle Nerve 22:640-644.
15. Vernino S, Auger RG, Amslie-Smith AM, Harper C, Lennon VA (1999). Myasthenia, thymoma, presynaptic antibodies, and a continuum of neuromuscular hyperexcitability. Neurology 53:1233-1239.
16. Vinik AI (1999). Diabetic neuropathy: pathogenesis and therapy. Am J Med 107:17S-26S.